EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Diagnosis and management of hemophilia A and B

Ming Y Lim, Jesús Ardila, Giancarlo Castaman, Yesim Dargaud, Karin Fijnvandraat, Roberta Gualtierotti, Cedric Hermans, Susan Shapiro

Journal of Thrombosis and Haemostasis · 2026-07 · 24 (7) · 2341-2354

DOI: 10.1016/j.jtha.2026.04.005 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026-07. Verfasst von Ming Y Lim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, Utah, USA. Electronic addre…. Hauptthemen laut MEDLINE: Hemophilia A, Hemophilia B, Coagulants, Blood Coagulation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Swedish Orphan Biovitrum, Bristol-Myers Squibb.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hemophilia A and hemophilia B are inherited bleeding disorders caused by a deficiency or absence of coagulation factor [F]VIII and FIX, respectively. The severity of bleeding manifestations generally correlates with the degree of factor deficiency, which is determined by the type of pathogenic variant in the F8 or F9 gene, both of which are located on the X-chromosome. The classical and most frequent site of bleeding is the musculoskeletal system, commonly into the ankle, knee, and elbow joints. Clinical diagnosis of hemophilia is typically confirmed through laboratory testing using 1-stage factor assays. The armamentarium of treatment includes desmopressin, FVIII/FIX concentrates, FVIII mimetics, rebalancing agents, and gene therapy. Despite advances in therapeutic options, hemophilic arthropathy remains a significant clinical complication. As life expectancy in persons with hemophilia increases, they become more susceptible to age-related comorbidities, including cardiovascular disease. Given the complex treatment modalities, hemophilia-specific complications, and quality-of-life concerns, optimal hemophilia care requires a multidisciplinary approach.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemophilia AHemophilia BCoagulantsBlood CoagulationHumansGenetic TherapyFactor IXFactor VIIIPhenotypeTreatment OutcomePredictive Value of TestsQuality of LifeGenetic Predisposition to Disease

Stichwörter der Autor:innen

diagnosisdisease managementhemophilia Ahemophilia Bpatient care teamstherapeutics

Substanzen

Factor IXFactor VIIICoagulants

Autor:innen und Institutionen

  • Department of Internal Medicine, Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, Utah, USA. Electronic address: ming.lim@hsc.utah.edu.
  • Fundación Clínica Infantil Club Noel, Servicio de Hematología y Oncología, Cali, Colombia; PS Especializada, Coagulopathies Program, Cali, Colombia.
  • Center for Bleeding Disorders and Coagulation, Department of Heart, Lungs, and Vessels, Careggi University Hospital, Florence, Italy.
  • French Reference Center for Hemophilia, Unite d'Hemosatse Clinique, Hopital Cardiologique Louis Pradel, Lyon, France.
  • Amsterdam University Medical Center, University of Amsterdam, Emma Children's Hospital, Pediatric Hematology, Meibergdreef 9, Amsterdam, the Netherlands.
  • Fondazione Institutes of Hospitalization and Healthcare with Scientific Goal Ca' Granda Ospedale Maggiore Policlinico, Centro Emofilia e Trombosi Angelo Bianchi Bonomi and Università degli Studi di Milano, Dipartimento…

Förderung

  • Swedish Orphan Biovitrum
  • Bristol-Myers Squibb

Zitieren

APA

Lim, M. Y., Ardila, J., Castaman, G., Dargaud, Y., Fijnvandraat, K., Gualtierotti, R., Hermans, C., & Shapiro, S. (2026). Diagnosis and management of hemophilia A and B. Journal of Thrombosis and Haemostasis, 24(7), 2341-2354. https://doi.org/10.1016/j.jtha.2026.04.005

Vancouver

Lim MY, Ardila J, Castaman G, Dargaud Y, Fijnvandraat K, Gualtierotti R, et al. Diagnosis and management of hemophilia A and B. Journal of Thrombosis and Haemostasis. 2026;24(7):2341-2354. doi:10.1016/j.jtha.2026.04.005

BibTeX
@article{Lim2026,
  author = {Lim, Ming Y and Ardila, Jesús and Castaman, Giancarlo and Dargaud, Yesim and Fijnvandraat, Karin and Gualtierotti, Roberta and Hermans, Cedric and Shapiro, Susan},
  title = {Diagnosis and management of hemophilia A and B},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2026},
  volume = {24},
  number = {7},
  pages = {2341--2354},
  doi = {10.1016/j.jtha.2026.04.005}
}
Kostenlos starten →